T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.85 CNY -4.53% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Teyi Pharmaceutical Group Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Teyi Pharmaceutical Group Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
T
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Additional Paid In Capital
ÂĄ836.8m
CAGR 3-Years
42%
CAGR 5-Years
27%
CAGR 10-Years
9%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Additional Paid In Capital
ÂĄ14.1B
CAGR 3-Years
0%
CAGR 5-Years
61%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Additional Paid In Capital
ÂĄ1.1B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Additional Paid In Capital
ÂĄ3.2B
CAGR 3-Years
-2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Additional Paid In Capital
ÂĄ17.6B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
30%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Additional Paid In Capital
ÂĄ858.7m
CAGR 3-Years
294%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
11.64 CNY
Undervaluation 24%
Intrinsic Value
Price
T

See Also

What is Teyi Pharmaceutical Group Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
836.8m CNY

Based on the financial report for Sep 30, 2024, Teyi Pharmaceutical Group Co Ltd's Additional Paid In Capital amounts to 836.8m CNY.

What is Teyi Pharmaceutical Group Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
9%

Over the last year, the Additional Paid In Capital growth was 14%. The average annual Additional Paid In Capital growth rates for Teyi Pharmaceutical Group Co Ltd have been 42% over the past three years , 27% over the past five years , and 9% over the past ten years .

Back to Top